Tinnitus
Conditions
Keywords
tinnitus
Brief summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in tinnitus clinical studies, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with tinnitus who may be invited to participate in clinical research in the years to come.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed with tinnitus * Willing to comply with all study related procedures and assessments * Ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
* No documented diagnosis of tinnitus * Any other health problems that would prohibit safe participation in the study * Pregnant or planning to become pregnant while enrolled in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of tinnitus patients who decide to enroll in a clinical study | 3 months |
| Rate of tinnitus patients who remain in a clinical study to completion | 12 months |